menactrims 2016 programme

Hosted by

March 17-19, 2016Le Royal Hotel

Amman, Jordan

In collaboration with

ASSO

CIA

TION

:

CO

NG

RESS P

OR

TAL:

ww

w.m

enactrim

s.com

2016.m

enactrim

s.com

REGISTER TODAY

Welcome NoteDear Colleagues,

On behalf of Middle East North Africa Committee for Research and Treatment in Multiple Sclerosis and its executive committee, it is my pleasure to invite you to participate in the Second MENACTRIMS Congress, which will take place from March 17th to 19th, 2016 in Amman, Jordan.

The congress aim is to provide a forum of excellence in MS education and research. Building on the collective efforts of the scientific committee, the meeting will deliver state-of-the-art presentations on MS by renowned international and regional keynote speakers. The content of the meeting includes up to date information on the latest treatments, clinical research, therapeutic strategies, imaging, epidemiology, differential diagnosis, risk factors, pregnancy, and much more.

The congress will convene over a two-day period to present major updates through plenary sessions, scientific symposia and teaching courses. This year’s congress will also feature parallel sessions addressed to nurses in collaboration with the International Organization of MS Nurses (IOMSN) and the Consortium of Multiple Sclerosis Centers (CMSC), and to regional MS societies in collaboration with the MS International Federation (MSIF). In

addition, the European Charcot Foundation will participate in the meeting for the first time through a scientific symposium.

The congress is also a great opportunity to meet and network with colleagues interested in the field of MS clinical care with more than 500 healthcare professionals from the MENA region expected to attend. We look forward to welcoming participants from all over the world to the lively cosmopolitan city of Amman.

Amman is a lively cosmopolitan fascinating city of contrasts – a unique blend of old and new, ideally situated on a hilly area between the desert and the fertile Jordan Valley. Jordan is a land steeped in history and has truly world-class sights such as Petra (one of the seven wonders of the world), Wadi Rum, Jerash and the Dead Sea, which form part of the magic that is Jordan.

We very much look forward to welcoming you in Amman.

Yours Sincerely,

Bassem I. Yamout, MD, FAANMENACTRIMS President

Org

aniz

ing

Com

mit

tee

. .

.

Scie

ntifi

c Co

mm

itte

e

Congress Committees

Prof. Bassem I YamoutMENACTRIMS President

Lebanon

Prof. Riadh GouiderMENACTRIMS Vice President

Tunisia

Dr. Mohammed Al-JummahMENACTRIMS Vice President

Saudi Arabia

Dr. Maurice DahdalehMENACTRIMS Treasurer

Jordan

Dr. Raed AlroughaniMENACTRIMS Secretary General

Kuwait

Prof. Saeed BohlegaMENACTRIMS Member

Saudi Arabia

Prof. Saher HashemMENACTRIMS Member

Egypt

Dr. Jihad InshasiMENACTRIMS MemberUnited Arab Emirates

Dr. Isa Alsharoqi MENACTRIMS Member

Bahrain

MENACTRIMS is an independent non-profit scientific organization that facilitates communication and creates synergies among clinicians and scientists to promote and enhance research and improve clinical outcomes in multiple sclerosis (MS). The main objectives of the organization are as follows:

• To support and promote basic and clinical research in multiple sclerosis in the Middle East and North Africa regions

• To act as representative of the multiple sclerosis research community• To be actively involved in coordinating initiatives in the field of research both

in our region and worldwide in collaboration with national and international MS organizations

• To establish National and Regional MS registries and to collaborate database in order to formulate a large MS registry

• To develop regular updated guidelines pertaining to diagnosis and therapy of MS in this region

• To organize at least bi-annual congresses in the field of treatment and research in multiple sclerosis

• To encourage young researchers in the field of multiple sclerosis.• To collaborate with relevant national and local associations in the region to

enhance MENACTRIMS mission.

Exec

utiv

e Co

mm

itte

e

Dr. Maurice Dahdaleh- Chair, Consultant Neurologist, Khalidi Hospital and Medical Center, Amman, Jordan

Dr. Jihad Inshasi- Co-Chair, Consultant Neurologist, Rashid Hospital & Dubai Medical College, Dubai, United Arab Emirates

Prof. Riadh Gouider, Head of Department and Consultant Neurologist, Razi Hospital, Tunis, Tunisia

Dr. Isa Alsharoqi, Consultant Neurologist, Salmaniya Medical Complex, Manama, Bahrain

Dr. Waleed Batayha, Consultant Neurologist, Ministry of Health, Amman, Jordan

Dr. Abdel Rahim Dwairi, Consultant Neurologist, Royal Medical Services, Amman, Jordan

Dr. Saeed Bohlega- Chair, Professor and Senior Consultant Neurologist, Department of Neurosciences, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia

Prof. Riadh Gouider- Co-chair, Consultant Neurologist and Head of Department, Razi Hospital, Tunis, Tunisia

Dr. Raed Alroughani, Director of MS Clinic, Amiri Hospital & Dasman Research Institute, Kuwait City, Kuwait


Dr. Saher Hashem, Professor and Consultant Neurologist, Faculty of Medicine, University of Cairo, Cairo, Egypt

Dr. Mohamad Sahraian, Associate Professor, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran

Dr. Majed Habahbeh, Consultant Neurologist, Royal Medical Services, Amman, Jordan

About MENACTRIMS

International Organization of MS Nurses (IOMSN) and the Consortium of Multiple Sclerosis Centers (CMSC) Multiple Sclerosis International Federation (MSIF)

MENACTRIMS Nursing Session

08:30-09:50 Session I08:30 Role of the MS Nurse J. Massouh

09:00 Clinical Evaluation Tools: MSFC, EDSS, QOL, Fatigue Scale, Hamilton Depression J. Massouh

09:30 Discussion09:50-10:20 Coffee Break

10:20-12:30 Session II

10:20 Symptomatic Management of MS Patients: What Nurses Need to Know I. Alsharoqi

10:50 Safety of DMDs in Pregnancy M. Zeineddine

11:20 Discussion

11:40 Case Discussion M. DahdalehJ. Inshasi

12:30-13:45 Lunch

13:45-16:40 Satellite Symposia: Managing MS Patients on DMTs13:45 Managing MS patients on DMTs I (Sponsored by Biologix)

14:25 Managing MS patients on DMTs II (Sponsored by Novartis)

15:05-15:20 Coffee Break

15:20 Managing MS patients on DMTs III (Sponsored by Genpharm)

16:00 Managing MS patients on DMTs IV (Sponsored by MerckSerono)

MS Organizations Session

14:00-15:30 Session I: The Role of MS Organizations

14:00 The MSIF: Who are we and how do we work with Local MS Organizations

MSIF Speaker TBA

14:20 How are MS Organisations Established and What is their Role?

MSIF Speaker TBA

14:50 MS Organizations in the West: How are they organized and what do they do?

MSIF Speaker TBA


16:00-17:30 Session II: Working Together: MS Organizations and Healthcare Professionals in the MENA Region

16:00 Cooperation between MS Societies and Healthcare Professionals

R. Alroughani

16:30 How can MS Organizations Inform People with MS about available Therapeutic Options I. Alsharoqi

17:15 Discussion

Day

3 M

arch

19,

201

6

Day

3 M

arch

19,

201

6

Second Middle East North Africa Committee for Research and Treatment in Multiple Sclerosis Congress

Day

2 M

arch

18,

201

6

08:00-08:45 Registration

08:45-09:15 Opening Ceremony09:15-11:15 PS I: Pathogenesis and Natural History of MS

09:15 Immunology of MS S. Khoury

09:40 The Pathology of MS and Other Inflammatory Demyelinating Diseases H. Lassman

10:05 Insight into the Course of MS through Imaging TBA

10:30 The Natural History of MS G. Giovannoni

10:55 Discussion11:15-13:00 Prayer and Lunch

13:00-13:45 SS I: Satellite Symposium (sponsored by Biologix)

13:45-15:05 PS II: Treatment of MS

13:45 The Role of Real World Studies in Assessing the Effectiveness of MS Therapies M. Trojano

14:00 MENACTRIMS Treatment Guidelines B. Yamout

14:35 Future Therapies in Relapsing Remitting MS L. Kappos

14:50 Discussion


15:30-16:50 PS III: Special Issues in MS15:30 Pediatric MS A. Boykov

15:55 Women’s Issues in MS S. Ibrahim

16:10 NMO Spectrum Disorders R. Alroughani

16:35 Discussion

16:50-17:35 SS II: Satellite Symposium (sponsored by MerckSerono)

Neuroradiology of MS MENACTRIMS-WFNRS Symposium

16:30-18:10 Session I16:30 Lesion Characteristics in Brain and Spinal Cord T. Yusri

16:50 MS Mimickers A. Rovira

17:10 MS Diagnostic Criteria: Past, Present & Future TBA

17:30 Advanced MRI Imaging in MS M. Wattjes


18:30-20:15 Session II18:30 The Role of MRI in Monitoring Disease Activity A. Rovira

18:50 Brain Atrophy: Its Role in MS TBA

19:10 Progressive Multifocal Leukoencephalopathy T. Yusri

19:30 Neuromyelitis Optica M. Wattjes

19:50 Discussion

Day

1 M

arch

17,

201

6

Second Middle East North Africa Committee for Research and Treatment in Multiple Sclerosis Congress

Day

3 M

arch

19,

201

6


12:45-13:45 Lunch

13:45-15:05 PS VI: Clinical Issues in MS

13:45 Genetic and Environmental Risk Factors in MS M. Etamedifar

14:05 The Role of Optical Coherence Tomography in MS C. Guevara

14:20 The Differential Diagnosis of MS S. Daoudi

14:35 Defining Suboptimal Response to Treatment in MS G. Giovannoni

14:50 Discussion

Day

3 M

arch

19,

201

6

08:00-09:00 Registration

09:00-10:20 PS IV: Controversies in MS

09:00 Radiologically Isolated Syndrome (RIS): Should we treat? M. Zakaria

09:15 Benign MS: Does it Exist? P. Rieckmann

09:40 Debate: Should we Stop DMTs in Patients with Long term Control of Disease Activity?

No: G. ComiYes: M. Khawaja

10:40-12:00 PS V: European Charcot Foundation Symposium Progressive MS: Where Do We Stand Today?

10:40 Pathological Mechanisms of Progressive MS H. Lassman

11:00 Disease Modifying Treatments in Progressive MS G. Comi

11:20 Future Therapies in Progressive MS L. Kappos

11:40 Electric and Magnetic Neuromodulation L. Leocani

12:00-12:45 SS III: Satellite Symposium (sponsored by Novartis)

15:05-15:35 SS IV: Satellite Symposium (sponsored by MerckSerono)


16:00-17:30 PS VII: Clinical Management of MS: Case StudiesPanelists: P. Rieckman, S. Bohlega, M. Aljumah

16:00 When to Switch or Escalate? R. Goueider

16:25 CIS: To Treat or not to Treat R. Obeid

16:50 The Dilemma of NMOSD E. Slassi

17:15 PML and MS in the MENA Region J. Saaedi

17:30-18:00 Closing Ceremony

Congress Information

Target Audience:Healthcare professionals and researchers involved in MS clinical care or research.

Congress Overview:• Full congress plenary sessions and

symposia • Symposium on neuroradiology in MS• European Charcot Foundation

Symposium• Half-day parallel session in

collaboration with the International Organization of MS Nurses (IOMSN) aimed at nurses

• Half-day parallel session in collaboration with the MS International Federation (MSIF) aimed at MENA region MS societies.

Congress Highlights:• Recent advances in MS therapy• MS and the Environment • Update review of MRI in MS • Immunology of MS• Epidemiology of MS• Differential Diagnosis of MS • Update on Secondary Progressive MS • Neuromyelitis Optica • Pediatric MS• MS and pregnancy• Symptomatic Management of MS

CME Accreditation:CME Accredited by the Jordan Medical Council. Under process.

Registration Schedule:

Group Registration:

Pass Early BirdJan. 15

StandardMar. 12 Onsite

Doctors USD 400 USD 450 USD 500

Non Doctors USD 200 USD 250 USD 300

The registration fee will cover tuition, symposium literature, certificate of attendance, lunch & coffee breaks for the Congress only.

Category Early BirdJan. 15

StandardMar. 12

Doctors USD 3600 USD 4000

Non Doctors USD 2000 USD 2500

Non-sponsoring companies that would like to purchase a group of delegates passes attending the congress may do so by using the special group registration fee. A group consists of a minimum of 10 persons as such:

Le Royal Hotel:Le Royal Hotel is an ultra-modern complex atop Jebal Amman that stands out as the city’s loftiest structure, lending importance to all the streets adjoining it. The hotel is located just 30 minutes away from the airport and offers its guests unequaled services and facilities.

Accommodation:Sponsors can book and pay for their hotel accommodation(s) through a direct online link that will provide the best group rates from the congress organisers. The following room options are provided:

Address:

Type Single Double

Deluxe USD 180 USD 195

Grand USD 265 USD 280

Rooms include morning breakfast and are price inclusive of 10% service charge and 16% government tax. Prices quoted above are subject to change. 1 JOD= 1.421 USD, 1 USD = 0.708 JOD

Le Royal Hotels & Resorts Amman

Post: Al Mutanabbi, Third Circle P.O. Box 52 Amman,11118 JordanTel +962 6 460 3038Fax +962 6 460 3002Web: www.leroyal.com/amman

PC

O:

LO

CA

L A

GEN

T:D

iaed

u

Jo

rdan

Val

ley

SpeakersProf. Saeed Bohlega, Professor and Senior Consultant Neurologist, King Faisal Specialist Hospital and Research Center, Riyadh, KSA

Prof. Alexey N. Boyko, Professor of Neurology, Director of the MS Center, Pirogov’s Russian National Research Medical University, MS Center at the Neuroclinica of Usupov’s Hospital, Moscow, Russia

Prof. Giancarlo Comi, Professor of Neurology, Department of Neurology and INSPE, Scientific Institute San Raffaele, Milan, Italy

Dr. Maurice Dahdale, Consultant Neurologist, Khalidi Hospital and Medical Center, Amman, Jordan

Dr. Smail Daoudi, Consultant Neurologist and Head of Neurology Department, University Hospital of Tizi Ouzou, Algiers, Algeria

Prof. Masoud Etamedifar, Professor of Neurology and Director, Isfahan MS Clinic, Isfahan, Iran

Prof. Gavin Giovannoni, Professor of Neurology, Royal London Hospital, Blizard Institute, London, UK

Prof. Riadh Gouider, Consultant Neurologist and Head of Department, Razi Hospital, Tunis, Tunisia

Prof. Jihad Inshasi, Consultant Neurologist, Rashid Hospital, Dubai, United Arab Emirates

Dr. Mohammed Al-Jummah, Professor and Consultant Neurologist, King Abdullah International Medical Research Center, Riyadh, KSA

Prof. Ludwig Kappos, Chair of Neurology, University Hospital Basel, Basel, Switzerland

Dr. Mona Al Khawajah, Consultant Neurologist, Assistant Professor, Al Faisal University, King Faisal Specialist Hospital & Research Center, Riyadh, KSA

Prof. Samia Khoury, Professor of Neurology, Director of Abou Haidar Neuroscience Institute and Multiple Sclerosis Center, American University of Beirut Medical Center, Beirut, Lebanon

Prof. Hans Lassmann, Professor of Neuroimmunology, Head of Department, Center for Brain Research, Vienna, Austria

Prof. Letizia Leocani, Professor of Neurology, Scientific Institute San Raffaele, Milan, Italy

Ms. Joelle Massouh, MS Nurse Specialist, American University of Beirut Medical Center, Beirut, Lebanon

Dr. Suzan Noori, Senior Consultant Neurologist, Assistant Professor of Neurology, University Hospital Sharjah, Sharjah, UAE

Dr. Rajaie Obaid , Consultant Neurologist, Private Practice, Indiana, USA

Dr. Celia Oreja-Guevara, Consultant Neurologist,Chief of Clinical Research at the Multiple Sclerosis Unit, University Hospital San Carlos, Madrid, Spain

Prof. Peter Rieckmann, Professor of Neurology, Director of the Neurological Clinic, Department of Neurology, Sozialstiftung Bamberg Hospital, Bamberg, Germany

Dr. Raed Alroughani, Consultant Neurologist and Director of MS Clinic, Amiri Hospital & Dasman Research Institute, Kuwait City, Kuwait

Dr. Alejandro Rovira, Consultant Neuroradiologist, Head of the Unit for RMI Neuroradiology, Vall d’Hebron University Hospital, Barcelona, Spain

Dr. Jameelah Saeedi, Professor of Neurology, King Fahad Medical City, Riyadh, KSA


Prof. Ilham Slassi, Professor of Neurology, Ibn Rochd Hospital, Casablanca, Morocco

Prof. Maria Trojano, Professor of Neurology, Chair of Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari, Bari, Italy

Dr. Mike Wattjes, Consultant Neuroradiologist, Department of Radiology & Nuclear Medicine, VU University Medical Center, Amsterdam, Netherlands

Prof. Bassem I. Yamout, Professor of Clinical Neurology, Director, Multiple Sclerosis Center Clinical Research, American University of Beirut Medical Center, Beirut, Lebanon

Prof. Tarek Yousry, Professor of Neuroradiology , University College of London Hospitals, London, UK

Prof. Magd Zakaria, Professor of Neurology, Ain Shams University, Cairo, Egypt

Dr. Maya Zeineddine, Pharmacist, MS Specialist, American University of Beirut Medical Center, Beirut, Lebanon

menactrims 2016 programme

Health & Medicine